Stock listing
OTC:MSRM Mushrooms, Inc. Stock
Follow Mushrooms, Inc. into a list and get an email when it puts out news.
Share price · OTC:MSRM
$0.012 USD -0.003 (-19.5%)
Close on Nov 20, 2026
- Day range
- $0.011 – $0.015 USDNov 20, 2026
- Volume
- 67,055 sharesNov 20, 2026
- Market cap
- $539,339 USDAt the close on Nov 20, 2026 · price × 44.94M shares outstanding
- 52-week range
- $0.0075 – $0.039 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $556 USDMedian day 234 shares · 32 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:MSRM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.012 | -0.003 | -19.5% | $0.015 | $0.015 | $0.011 | 67,055 | |
| $0.015 | -0.002 | -12.4% | $0.017 | $0.017 | $0.0075 | 1,049,529 | |
| $0.017 | -0.001 | -4.0% | $0.017 | $0.017 | $0.017 | 75,000 | |
| $0.018 | +0.001 | +3.5% | $0.018 | $0.018 | $0.018 | 150,500 | |
| $0.017 | +0.000 | +1.8% | $0.016 | $0.017 | $0.016 | 10,400 | |
| $0.017 | +0.002 | +12.0% | $0.015 | $0.017 | $0.015 | 30,000 | |
| $0.015 | +0.001 | +4.2% | $0.016 | $0.016 | $0.015 | 90,250 | |
| $0.014 | -0.003 | -18.6% | $0.014 | $0.014 | $0.014 | 13,100 | |
| $0.018 | 0.000 | -1.1% | $0.018 | $0.018 | $0.018 | 60,000 | |
| $0.018 | +0.000 | +1.1% | $0.018 | $0.018 | $0.018 | 35,000 | |
| $0.018 | 0.000 | -1.7% | $0.018 | $0.018 | $0.018 | 38,000 | |
| $0.018 | 0.000 | 0.0% | $0.018 | $0.018 | $0.018 | 17,000 | |
| $0.018 | +0.000 | +1.7% | $0.018 | $0.018 | $0.018 | 60,000 | |
| $0.018 | +0.002 | +15.7% | $0.016 | $0.019 | $0.016 | 305,259 | |
| $0.015 | -0.001 | -6.1% | $0.015 | $0.015 | $0.015 | 17,718 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 30,000 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 6,000 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | +0.002 | +13.2% | $0.014 | $0.016 | $0.014 | 468 | |
| $0.014 | -0.002 | -11.7% | $0.014 | $0.014 | $0.014 | 1,950 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | +0.002 | +13.2% | $0.016 | $0.016 | $0.016 | 2,500 | |
| $0.014 | 0.000 | 0.0% | $0.014 | $0.014 | $0.014 | 0 | |
| $0.014 | 0.000 | 0.0% | $0.014 | $0.014 | $0.014 | 0 | |
| $0.014 | +0.002 | +16.1% | $0.014 | $0.014 | $0.014 | 1,000 | |
| $0.012 | 0.000 | 0.0% | $0.012 | $0.012 | $0.012 | 0 | |
| $0.012 | 0.000 | 0.0% | $0.012 | $0.012 | $0.012 | 0 | |
| $0.012 | 0.000 | 0.0% | $0.012 | $0.012 | $0.012 | 0 | |
| $0.012 | 0.000 | 0.0% | $0.012 | $0.012 | $0.012 | 0 | |
| $0.012 | 0.000 | 0.0% | $0.012 | $0.012 | $0.012 | 0 | |
| $0.012 | 0.000 | 0.0% | $0.012 | $0.012 | $0.012 | 0 | |
| $0.012 | -0.004 | -23.5% | $0.012 | $0.013 | $0.012 | 8,670 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 10,000 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | -0.6% | $0.012 | $0.016 | $0.012 | 13,897 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.011 | $0.016 | $0.011 | 16,610 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | +0.002 | +14.0% | $0.011 | $0.016 | $0.011 | 17,200 | |
| $0.014 | 0.000 | 0.0% | $0.014 | $0.014 | $0.014 | 0 | |
| $0.014 | 0.000 | 0.0% | $0.014 | $0.014 | $0.014 | 0 | |
| $0.014 | +0.001 | +8.3% | $0.014 | $0.014 | $0.014 | 3,500 | |
| $0.013 | 0.000 | 0.0% | $0.014 | $0.014 | $0.013 | 500 | |
| $0.013 | 0.000 | 0.0% | $0.013 | $0.013 | $0.013 | 0 | |
| $0.013 | -0.003 | -18.5% | $0.013 | $0.013 | $0.013 | 30,000 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | 0.000 | 0.0% | $0.016 | $0.016 | $0.016 | 0 | |
| $0.016 | +0.001 | +9.5% | $0.016 | $0.016 | $0.011 | 54,925 | |
| $0.015 | 0.000 | 0.0% | $0.015 | $0.015 | $0.015 | 0 | |
| $0.015 | 0.000 | -2.6% | $0.014 | $0.015 | $0.014 | 908 | |
| $0.015 | 0.000 | -0.7% | $0.015 | $0.016 | $0.015 | 31,250 | |
| $0.015 | 0.000 | 0.0% | $0.015 | $0.015 | $0.015 | 0 | |
| $0.015 | 0.000 | 0.0% | $0.015 | $0.015 | $0.015 | 0 | |
| $0.015 | 0.000 | 0.0% | $0.015 | $0.015 | $0.015 | 0 | |
| $0.015 | 0.000 | 0.0% | $0.015 | $0.015 | $0.015 | 0 |
Splits
1 split · OTC:MSRM · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-500 | Consolidation |
- Ticker
- OTC:MSRM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Mar 24, 2026
Mushrooms Inc. (OTC: MSRM) Achieves Proof of Concept for MycoLabX Infection-Detection Technology and Provides Strategic Update
Latest news
Mushrooms Inc. (OTC: MSRM) Achieves Proof of Concept for MycoLabX Infection-Detection Technology and Provides Strategic Update
Mar 24, 2026
Closed $0.016 (+22.5%) on Mar 24, 2026
Mushrooms, Inc. (OTC: MSRM) Signs Share Exchange Agreement to Acquire SecurCapital Corp
Jan 29, 2026
Closed $0.024 (-20.0%) on Jan 29, 2026
Mushrooms, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 2 in the last 12 months · 34 in all · newest Mar 24, 2026 · oldest 2017
Valuation
Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $564,177 USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 1.24
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Mushrooms, Inc. · OTC:MSRM | US$539,339 | US$564,177 | n/a | n/a | n/a | n/a | n/a | n/a | 1.24 |
| Gabather AB · OMXSTO:GABA | US$919,514 | US$559,105 | n/a | n/a | n/a | 6.4× | n/a | 0.0× | n/a |
| ExpreS2ion Biotech Holding AB · OMXSTO:EXPRS2 | US$792,634 | −US$2.43M | n/a | −6.5× | n/a | 0.2× | −935.9% | 0.0× | n/a |
| Silexion Therapeutics Corp · NASDAQ:SLXN | US$790,001 | −US$3.60M | n/a | n/a | n/a | 0.3× | n/a | 0.1× | 2.77 |
| Oragenics Inc. · AMEX:OGEN | US$708,377 | −US$1.12M | n/a | n/a | n/a | 0.7× | n/a | 0.4× | 1.47 |
| Protagenic Therapeutics, Inc. · OTC:PTIX | US$687,879 | US$610,970 | 0.1× | n/a | n/a | 0.6× | n/a | 0.0× | 1.21 |
| Lakewood-Amedex Biotherapeutics Inc. · NASDAQ:LABT | US$580,337 | −US$2.74M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 0.46 |
| Jaguar Health, Inc. · NASDAQ:JAGX | US$527,406 | −US$1.48M | n/a | −0.1× | n/a | 0.0× | −181.8% | 0.2× | 3.75 |
| Altamira Therapeutics Ltd. · OTC:CYTOF | US$404,655 | US$400,900 | n/a | n/a | n/a | 0.1× | n/a | 0.0× | 0.64 |
| NKGen Biotech Inc. · OTC:NKGN | US$391,807 | US$38.58M | n/a | n/a | n/a | n/a | n/a | n/a | 0.88 |
| Vaxil Bio Ltd. · TSXV:VXL | US$319,522 | −US$4,071 | 1.2× | n/a | n/a | 0.4× | n/a | 0.0× | -0.16 |
| Median of the others | US$634,108 | −US$563,244 | 0.7× | −3.3× | 0.3× | −558.9% | 0.0× | 1.05 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.38K | 979 | 5.26K | 10.8K | 78.6K | 274.0K | 3.32K | |||
| Cost of revenue | 3.43K | 2.17K | 2.90K | 1.39K | 2.37K | 7.66K | ||||
| Gross profit | -1.05K | -1.19K | -2.90K | -1.39K | 5.26K | 10.8K | 78.6K | 271.6K | -4.34K | |
| Research and development | 1.00K | 7.51K | 511 | |||||||
| Operating income | -24.8K | -10.3K | -296.4K | -704.5K | -636.4K | -69.4K | -59.9K | -274.1K | -111.8K | -140.8K |
| Depreciation and amortization | 2.19K | 2.13K | 2.13K | 1.39K | 236.6K | 206.3K | 171.9K | 1.36K | 762 | |
| EBITDA | -22.6K | -8.16K | -294.3K | -703.1K | -399.9K | 136.9K | 112.0K | -110.4K | -140.0K | |
| Interest expense | 464 | 36 | 1.58K | 5.09K | ||||||
| Income before tax | -25.2K | -10.6K | -296.4K | -704.5K | -657.2K | -69.5K | -61.8K | -198.9K | -113.4K | -197.9K |
| Income tax | 4 | 5 | -236.6K | -206.3K | -171.9K | -30.1K | -2 | |||
| Net income | -25.2K | -10.6K | -296.4K | -704.5K | -657.2K | -69.5K | -61.8K | -168.9K | -113.4K | -197.9K |
| Earnings per share, basic | -0.00 | -0.00 | -0.01 | -0.02 | -0.04 | -0.24 | -0.41 | -1.28 | -5.02 | -21.66 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 106 | 290 | 2.95K | 559 | 8.48K | 21.1K | 15.3K | 1.27K | ||
| Receivables | 115.6K | 115.6K | 115.6K | 265.0K | ||||||
| Inventory | 8.16K | 8.23K | 10.6K | 4.76K | ||||||
| Current assets | 8.27K | 8.52K | 30.1K | 21.8K | 25.0K | 37.5K | 153.1K | 146.8K | 280.3K | 1.27K |
| Total assets | 13.0K | 15.4K | 32.3K | 26.0K | 25.0K | 37.5K | 153.1K | 148.6K | 303.1K | 8.64K |
| Accounts payable | 9.24K | 3.31K | 1.41K | 69.4K | 65.5K | 38.5K | 25.8K | 62.3K | 48.6K | |
| Current liabilities | 52.0K | 36.3K | 174.4K | 182.1K | 135.9K | 92.3K | 45.3K | 35 | 759.3K | 77.9K |
| Total debt | 25.0K | 28.2K | 28.2K | 3.23K | 4.54K | 6.30K | 17.1K | 6.30K | 697.0K | 29.2K |
| Total liabilities | 77.0K | 61.3K | 199.4K | 182.1K | 135.9K | 92.3K | 45.3K | 6.33K | 772.4K | 91.0K |
| Shareholders' equity | -64.1K | -45.9K | -167.1K | -156.1K | -110.9K | -54.7K | 107.8K | 142.3K | -469.3K | -82.4K |
| Shares outstanding | 39.6M | 39.4M | 38.0M | 29.1M | 16.0M | 287.9K | 149.0K | 131.7K | 22.6K | 9.14K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1.41K | -4.04K | -30.7K | -2.38K | -21.5K | -12.7K | -60.5K | 5.79K | -97.3K | -167.9K |
| Capital spending | -5 | -4 | -998 | -5.54K | 0 | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | 1.41K | -4.05K | -62.6K | -7.92K | -21.5K | -12.7K | -60.5K | 5.79K | -97.3K | -167.9K |
| Cash from investing | 1.20K | -5.54K | 28.6K | 67.6K | ||||||
| Cash from financing | -1.60K | -75 | 35.8K | 30.0K | 10.8K | 111.4K | 15.0K | |||
| Change in cash | -184 | -4.14K | 3.87K | -7.92K | 8.48K | -12.7K | -21.1K | 5.79K | 14.1K | -85.2K |
Cap table
Built by 6ix from Mushrooms, Inc.’s releases
- Common shares
- 44,944,916
- Fully diluted
- 44,944,916
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 44,944,916 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 44,944,916 |
Log in to ask 6ix AI your own questions about Mushrooms, Inc.